190+ speakers - more to come!


Innovation across biotech, medtech and healthtech

See speakers in the separate streams below or download the brochure here

Biotech Leaders
Medtech Leaders
Healthtech Leaders

Renee Aguiar-Lucander, CEO, Calliditas Therapeutics

Renee Aguiar-Lucander

CEO
Calliditas Therapeutics
Khatereh Ahmadi, Head of Search and Evaluation Europe and Middle East BD&L Team, MSD Ltd

Khatereh Ahmadi

Head of Search and Evaluation Europe and Middle East BD&L Team
MSD Ltd
Mehdi Ainouche, Principal, Jeito

Mehdi Ainouche

Principal
Jeito
Maarten Akkerman, Head Medical Affairs & Value Based Healtcare, Medtronic

Maarten Akkerman

Head Medical Affairs & Value Based Healtcare
Medtronic
Michael Altorfer, Chief Executive Officer, Swiss Biotech Association

Michael Altorfer

Chief Executive Officer
Swiss Biotech Association
Madeleine Armstrong, News Editor, Evaluate

Madeleine Armstrong

News Editor
Evaluate
David Atkins, Chief Executive Officer, Congenica

David Atkins

Chief Executive Officer
Congenica
Gwilym Attwell, Principal, Fish & Richardson

Gwilym Attwell

Principal
Fish & Richardson
Assaf Barnea, CEO, Sanara Ventures

Assaf Barnea

CEO
Sanara Ventures
Luc Behr, Co-Founder and Scientific Director, IMMR

Luc Behr

Co-Founder and Scientific Director
IMMR, now a part of Veranex
Mats Berggren, Head of Digital Growth Opportunities and Innovation, Merck

Mats Berggren

Head of Digital Growth Opportunities and Innovation
Merck
Xavier Bertrand, VP & GM EMEA Healthcare Services and Alliances, Boston Scientific

Xavier Bertrand

VP & GM EMEA Healthcare Services and Alliances
Boston Scientific
Robin Bhattacherjee, CEO, Actimed Therapeutics

Robin Bhattacherjee

CEO
Actimed Therapeutics
Hubert Birner, Managing Partner, TVM Life Science

Hubert Birner

Managing Partner
TVM Life Science
Martin-Immanuel Bittner, CEO, Arctoris

Martin-Immanuel Bittner

CEO
Arctoris
Georg Bortlein, CEO, Highlife Medical

Georg Bortlein

CEO
Highlife Medical
Peter Bowness, Director, International Regulatory Affairs, MCRA; Former Senior Regulator, BSI

Peter Bowness

Director, International Regulatory Affairs, MCRA
Former Senior Regulator, BSI
Florian Brand, CEO, ATAI Life Sciences

Florian Brand

CEO
ATAI Life Sciences
Samana Brannigan, Innovation Lead and Investor Relations, Innovate UK 300x

Samana Brannigan

Head of Health Technologies
Innovate UK
Eduardo Bravo, CEO, EBAC (European Biotech Acquisition Corporation)

Eduardo Bravo

CEO
EBAC (European Biotech Acquisition Corporation)
Viola Bronsema, CEO and Secretary General, BIO Deutschland

Viola Bronsema

CEO and Secretary General
BIO Deutschland
Seamus Browne, Head of Industry Partnerships, Royal College of Surgeons in Ireland

Seamus Browne

Head of Industry Partnerships
Royal College of Surgeons in Ireland
Roel Bulthuis, Managing Director, INKEF Capital

Roel Bulthuis

Managing Director
INKEF Capital
Drew Burdon, Investment Manager, LSP

Drew Burdon

Investment Manager
LSP
Jose Calle Gordo, Managing Partner, Valiance

Jose Calle Gordo

Managing Partner
Valiance
Matt Cardinal, VP Strategy & Program Leadership, Halloran

Matt Cardinal

VP Strategy & Program Leadership
Halloran
Dean Chapman, Director (People + Cyber Solutions), Willis Towers Watson

Dean Chapman

Director (People + Cyber Solutions)
Willis Towers Watson
Alain Chevallier, Senior Partner, Truffle Capital

Alain Chevallier

Senior Partner
Truffle Capital
Paolo Cionini, Chief Commercial Officer, Almirall

Paolo Cionini

Chief Commercial Officer
Almirall
Djork-Arne Clevert, Director Machine Learning, Bayer

Djork-Arne Clevert

Director Machine Learning
Bayer
Jean-Philippe Combal, CEO, Vivet Therapeutics

Jean-Philippe Combal

CEO
Vivet Therapeutics
Yuehua Cong, BD Executive Director, Simcere Pharmaceutical Group

Yuehua Cong

BD Executive Director
Simcere Pharmaceutical Group
Juliette Cook, Vice President Quality and Regulatory Affairs, Implantica Management AG

Juliette Cook

Vice President Quality and Regulatory Affairs
Implantica Management AG
Ian Crosbie, CEO, Sequana Medical NV

Ian Crosbie

CEO
Sequana Medical NV
Maria Dahl, Chief Operating Officer and Head, Europe, Innovent Biologics

Maria Dahl

Chief Operating Officer and Head, Europe
Innovent Biologics
Mark Davies, Chief Medical Officer EMEA, IBM Watson Health

Mark Davies

Chief Medical Officer EMEA
IBM Watson Health
John Dawson, CEO, Oxford Biomedica

John Dawson

CEO
Oxford Biomedica
Susana de Azevedo Wäsch, VP Quality Management & Regulatory Affairs, Ypsomed

Susana de Azevedo Wäsch

VP Quality Management & Regulatory Affairs
Ypsomed
Lucas de Breed, Founder, August

Lucas de Breed

Founder
August
Ros Deegan, CEO, OMass Therapeutics

Ros Deegan

CEO
OMass Therapeutics
Annemijn Eschauzier, Mentor; former CMO Women's Health, GE

Annemijn Eschauzier

Mentor
former CMO Women's Health, GE
Louise Farley, Partner, Deepbridge Capital

Louise Farley

Partner
Deepbridge Capital
Peter Finnie, Partner, Potter Clarkson

Peter Finnie

Partner
Potter Clarkson
Rachel Ford Hutman, Founder and CEO, Ford Hutman Media

Rachel Ford Hutman

Founder and CEO
Ford Hutman Media
Jason Foster, CEO, Ori Biotech

Jason Foster

CEO
Ori Biotech
Jonathan Fox, Managing Director, Digital, Deloitte

Jonathan Fox

Managing Director, Digital
Deloitte
Chris Garabedian, Chairman and CEO, Xontogeny

Chris Garabedian

Chairman and CEO
Xontogeny
Arpa Garay, President, Global Pharmaceuticals, Digital, Merck

Arpa Garay

President, Global Pharmaceuticals, Digital
Merck
Robert Garber, Partner, 7Wire Ventures

Robert Garber

Partner
7WireVentures
David Germonpré, Investment Partner, MTIP

David Germonpré

Investment Partner
MTIP
Dominique Gilsoul, Global Market Access Leader - Medical & Clinical Affairs - Healthcare Business Group, 3M

Dominique Gilsoul

Global Market Access Leader - Medical & Clinical Affairs - Healthcare Business Group
3M
Jonathan Goldstein, Director, Global Technology Partnerships, Boston Scientific

Jonathan Goldstein

Director, Global Technology Partnerships
Boston Scientific
Neil Gomes, System SVP, Digital Human Experiences, Common Spirit Health

Neil Gomes

System SVP, Digital Human Experiences
Common Spirit Health
Gregoire Guillet, Chief Business & Value Officer – WeHealth Digital Medicine, Servier

Gregoire Guillet

Chief Business & Value Officer – WeHealth Digital Medicine
Servier
Andrew Hack, Managing Director, Bain Capital Life Sciences

Andrew Hack

Managing Director
Bain Capital Life Sciences
Brian Hakim, Director Business Development, MedTecX

Brian Hakim

Director Business Development
MedTecX
Alex Hamilton, Partner, Syncona

Alex Hamilton

Partner
Syncona
Giles Hamilton, CEO, ODx Innovations

Giles Hamilton

CEO
ODx Innovations
Luke Hares, CTO, CMR Surgical

Luke Hares

CTO
CMR Surgical
Deborah Harland, Partner, SR One

Deborah Harland

Partner
SR One
Ali Hasan, Chief Medical & Healthcare Officer, Vitality

Ali Hasan

Chief Medical & Healthcare Officer
Vitality
Bill Haynes, Head of Novo Nordisk Research Centre Oxford, Novo Nordisk

Bill Haynes

Head of Novo Nordisk Research Centre Oxford
Novo Nordisk
Olav Hellebo, CEO, ReNeuron Group

Olav Hellebo

CEO
ReNeuron
Zach Henderson, Chief Commercial Officer, Glooko

Zach Henderson

Chief Commercial Officer
Glooko
Madelyn Herzfeld, Founder & Vice Chairman, Carevive

Madelyn Herzfeld

Founder & Vice Chairman
Carevive
William Hicks, Co-chair Securities & Capital Markets Group, Mintz

William Hicks

Co-chair Securities & Capital Markets Group
Mintz
Berthold Hinzen, Head of BD&L Therapeutic Areas, Bayer

Berthold Hinzen

Head of BD&L Therapeutic Areas
Bayer
Ben Hohn, Principal - BD, Pipeline and Launch Strategy & Emerging Pharma Lead, ZS Associates, Inc

Ben Hohn

Principal - BD, Pipeline and Launch Strategy & Emerging Pharma Lead
ZS Associates, Inc
Anne Horgan, Partner, Cambridge Innovation Capital

Anne Horgan

Partner
Cambridge Innovation Capital
Baudouin Hue, Partner, Karista

Baudouin Hue

Partner
Karista
Thomas Hummel, Head of Strategy and Innovation, Digital Health, Siemens Healthineers

Thomas Hummel

Head of Strategy and Innovation, Digital Health
Siemens Healthineers
Sofia Ioannidou, Partner, Andera Partners

Sofia Ioannidou

Partner
Andera Partners
Pierre-Louis Joffrin, CDO, Mogrify

Pierre-Louis Joffrin

CDO
Mogrify
Neil Jordan, WW General Manager Retail Health Innovation, Microsoft

Neil Jordan

WW General Manager Retail Health Innovation
Microsoft
Wouter Joustra, General Partner, Forbion 300x

Wouter Joustra

General Partner
Forbion
Marc Julien, CEO, Diabeloop

Marc Julien

CEO
Diabeloop
Markus Kalousek, Global Head of Pharma S&E, Novartis

Markus Kalousek

Global Head of Pharma S&E
Novartis
Oliver Keown, Head of Venture, Intuitive Surgical

Oliver Keown

Head of Venture
Intuitive Surgical
Maya Khurana, Health and Life Sciences Director, Oliver Wyman

Maya Khurana

Health and Life Sciences Director
Oliver Wyman
Sven Kili, Chief Executive Officer, Antion Biosciences SA

Sven Kili

Chief Executive Officer
Antion Biosciences SA
Jan Kimpen, Chief Medical Officer, Philips

Jan Kimpen

Chief Medical Officer
Philips
Linda Korthout, Director International Clinical Affairs, MCRA

Linda Korthout

Director International Clinical Affairs
MCRA
Charity Kufaas, VP, Strategy & Business Development EMEA, Medtronic

Charity Kufaas

VP, Strategy & Business Development EMEA
Medtronic
Dima Kuzmin, Managing Director, 4BIO Capital

Dima Kuzmin

Managing Director
4BIO Capital
Paul Landau, CEO, Careology

Paul Landau

CEO
Careology
Adam Landman, Chief Information and Digital Officer, Brigham and Women’s Hospital 300x

Adam Landman

Chief Information and Digital Innovation Officer
Brigham Women’s Hospital
Werner Lanthaler, Chief Executive Officer, Evotec International GmbH

Werner Lanthaler

Chief Executive Officer
Evotec International GmbH
Jin Lee, Director Digital Health, Astellas Pharma Inc

Jin Lee

Director Digital Health
Astellas Pharma Inc
Keren Leshem, CEO, Ocon Healthcare

Keren Leshem

CEO
Ocon Healthcare
Marta Helena Lesko, Head of BD Enabling Technologies, Merck KGaA

Marta Helena Lesko

Head of BD Enabling Technologies
Merck KGaA
Sergio Levi, Vice President Strategic Alliances, Philips

Sergio Levi

Vice President Strategic Alliances
Philips
Bruce Lichorowic, President & CEO, Galen Robotics

Bruce Lichorowic

President & CEO
Galen Robotics
Peter Llewellyn-Davies, CEO, APEIRON

Peter Llewellyn-Davies

CEO
APEIRON
Nicoletta Loggia, CTO, Orchard Therapeutics

Nicoletta Loggia

CTO
Orchard Therapeutics
Rana Lonnen, Head of Search and Evaluation, Strategic Capital, Novartis

Rana Lonnen

Managing Director, dRx Capital
Novartis
Philippe Lopes-Fernandes, SVP, Global Head of BD & Alliance Management, Merck Serono 300x

Philipe Lopes Fernandes

CBO
Ipsen
Tim Luker, VP Venture Science, Corporate BD, Eli Lilly

Tim Luker

VP Venture Science, Corporate BD
Eli Lilly
Gavin MacGregor, Investment Advisor Public Equity, HBM Partners

Gavin MacGregor

Investment Advisor Public Equity
HBM Partners
Lucy Mackillop, Chief Medical Officer, Sensyne Health

Lucy Mackillop

Chief Medical Officer
Sensyne Health
Franklin Maddux, Global CMO, Fresenius Medical Care

Franklin Maddux

Global CMO
Fresenius Medical Care
Priya Mande, Interim CEO, PsiOxus Therapeutics

Priya Mande

Interim CEO
PsiOxus Therapeutics
Dan Marshall, Director Business Development, MSD

Dan Marshall

Director Business Development
MSD
Mark McCarthy, Executive Director, Human Genetics; Senior Fellow, Genentech

Mark McCarthy

Executive Director, Human Genetics; Senior Fellow
Genentech
Jessica McCreadie, Principal, Octopus Ventures

Jessica McCreadie

Principal
Octopus Ventures
Robbie McLaren, Partner, Latham & Watkins

Robbie McLaren

Partner
Latham & Watkins
Jason Mellad, CEO, Start Codon

Jason Mellad

CEO
Start Codon
John Milad, CEO, Quanta Dialysis Technologies

John Milad

CEO
Quanta Dialysis Technologies
Elizabeth Mily, EVP Strategy & BD, Bristol Myers Squibb

Elizabeth Mily

EVP Strategy & BD
Bristol Myers Squibb
Berndt Modig, CEO, Pharvaris

Berndt Modig

CEO
Pharvaris
Parker Moss, Chief Commercial Officer, Genomics England

Parker Moss

Chief Commercial Officer
Genomics England
Jukka Muhonen, Director of Global Business Development and Alliance Management, Orion Corporation

Jukka Muhonen

Director of Global Business Development and Alliance Management
Orion Corporation
Matthias Müllenbeck, Senior Vice President and Head of Global Business Development & Alliance Management, Merck KGaA

Matthias Müllenbeck

Senior Vice President and Head of Global Business Development & Alliance Management
Merck KGaA
Karl Nägler, Managing Partner, Wellington Partners

Karl Nägler

Managing Partner
Wellington Partners
Anat Naschitz, Venture Partner, Orbimed

Anat Naschitz

Venture Partner
Orbimed
Arif Nathoo, CEO, Komodo Health

Arif Nathoo

CEO
Komodo Health
Daniel Neil, SVP AI, Benevolent

Daniel Neil

SVP AI
Benevolent.ai
Michael Niddam, Co-Founder, Kamet Ventures 300x

Michael Niddam

Co-Founder & Managing Director
Kamet Ventures
Laura Niklason, CEO, Humacyte

Laura Niklason

CEO
Humacyte
David Norton, Senior Lead Innovation Consultant, Royal Free London Foundation Trust

David Norton

Senior Lead Innovation Consultant
Royal Free London Foundation Trust
Caroline Noublanche, CEO, Apricity

Caroline Noublanche

CEO
Apricity
Geraldine O’Keeffe, Partner, LSP

Geraldine O'Keeffe

Partner
LSP
John Orwin, CEO, Atreca

John Orwin

CEO
Atreca
Anne Osdoit, Partner, Sofinnova

Anne Osdoit

Partner
Sofinnova
Markus Ott, Head Global Market Access & Health Policy, Roche

Markus Ott

Head Global Market Access & Health Policy
Roche
Tej Panesar, Investment Director - Life Sciences, British Patient Capital

Tej Panesar

Investment Director - Life Sciences
British Patient Capital
Max Parmentier, Chief Executive Officer & Co-Founder, Birdie

Max Parmentier

Chief Executive Officer & Co-Founder
Birdie
Rebecca Pope, UK Digital & Data Science Innovation Lead, Roche

Rebecca Pope (she/her)

UK Digital & Data Science Innovation Lead
Roche
Cody Powers, Principal, ZS Associates

Cody Powers

Principal
ZS Associates
Lord David Prior, Chairman, NHS

Lord David Prior

Chairman
NHS
Tony Proctor, Partner, Potter Clarkson

Tony Proctor

Partner
Potter Clarkson
Gil Rabbie, Digital Solutions & Capability Development Leader, Boston Scientific

Gil Rabbie

Digital Solutions & Capability Development Leader
Boston Scientific
Andrea Rappagliosi, Vice President Market Access, Public Affairs & Communication EMEA, Canada and LATAM, Edwards Lifesciences

Andrea Rappagliosi

VPMarket Access, Public Affairs & Communication EMEA, Canada & LATAM
Edwards Lifesciences
Nazar Rasul, VP Global Head of Digital, Fresenius Kabi

Nazar Rasul

VP Global Head of Digital
Fresenius Kabi
Bleddyn Rees, Chair, The Digital Health Society; Board Director, ECHAlliance

Bleddyn Rees

Chair, The Digital Health Society
Board Director, ECHAlliance
Brad Robling, VP Corporate Business Development, Eli Lilly

Brad Robling

VP Corporate Business Development
Eli Lilly
Chris Robson, CEO, Living With

Chris Robson

CEO
Living With
Rajeev Ronanki, President, Digital Platforms, Anthem

Rajeev Ronanki

President, Digital Platforms
Anthem
Kieran Rooney, VP, Strategic Alliances and Licensing, Amryt Pharma

Kieran Rooney

VP, Strategic Alliances and Licensing
Amryt Pharma
Christina Rossi, Chief Commercial Officer, Blueprint Medicines

Christina Rossi

Chief Commercial Officer
Blueprint Medicines
Anya Roy, Head of Seed Investments & Technology EMEA, Illumina

Anya Roy

Head of Seed Investments & Technology EMEA
Illumina
Gunnar Sachs, Partner, Clifford Chance

Gunnar Sachs

Partner
Clifford Chance
Neil Sahota, United Nations Artificial Intelligence Advisor & Interim CEO, ACSILabs

Neil Sahota

United Nations Artificial Intelligence Advisor & Interim CEO
ACSILabs
Ed Saltzman, Executive Chairman, Cello Health BioConsulting

Ed Saltzman

Executive Chairman
Cello Health BioConsulting
Antonio Sanchez-Cordero, WW VP Business Development & Strategy, Becton Dickinson

Antonio Sanchez-Cordero

WW VP Business Development & Strategy
Becton Dickinson
Diana Saraceni, Managing Partner, Panakès Partners

Diana Saraceni

Managing Partner
Panakès Partners
Isabella Schidrich, Senior Managing Director, Nasdaq

Isabella Schidrich

Senior Managing Director
Nasdaq
Eliane Schutte, Chief Executive Officer, Xeltis B.V.

Eliane Schutte

Chief Executive Officer
Xeltis B.V.
Graziano Seghezzi, Managing Partner, Sofinnova

Graziano Seghezzi

Managing Partner
Sofinnova
Nigel Sheail, Global Head of M&A and BD&L, Novartis

Nigel Sheail

Global Head of M&A and BD&L
Novartis
Tom Shepherd, CEO, Captor Therapeutics

Tom Shepherd

CEO
Captor Therapeutics
João Siffert, CEO & President, Design Therapeutics

João Siffert

CEO & President
Design Therapeutics
Tobias Silberzahn, Partner, McKinsey

Tobias Silberzahn

Partner
McKinsey
Ari Silverman, Partner, Mavie Technologies

Ari Silverman

Partner
Mavie Technologies
Stephanie Sirota, Partner and Chief Business Officer, RTW Investments

Stephanie Sirota

Partner and Chief Business Officer
RTW Investments
Ulrica Slåne Bjerke, CIO, Arctic Aurora LifeScience

Ulrica Slåne Bjerke

CIO
Arctic Aurora LifeScience
Sander Slootweg, Co-Owner & Managing Partner, Forbion Capital Partners

Sander Slootweg

Co-Owner & Managing Partner
Forbion Capital Partners
Laurie Smaldone Alsup, CMO/CSO, NDA Group

Laurie Smaldone Alsup

CMO/CSO
NDA Group
Graeme Smith, CEO, Lightpoint Medical

Graeme Smith

CEO
Lightpoint Medical
Jon Speer, Founder, Greenlight Guru 300x

Jon Speer

Founder
Greenlight Guru
Emma Stanton, VP Clinical, Oxford Nanopore Technologies

Emma Stanton

VP Clinical
Oxford Nanopore Technologies
Rhoda Steel, Head of Community Impact, Johnson & Johnson UK

Rhoda Steel

Head of Community Impact
Johnson & Johnson UK
Anette Steenberg, CEO, Medicon Valley Alliance

Anette Steenberg

CEO
Medicon Valley Alliance
Kári Stefánsson, Chief Executive Officer, deCODE Genetics

Kári Stefánsson

Chief Executive Officer
deCODE Genetics
Jacob Sten Petersen, Corporate VP, Head of Stem Cell R&D, Novo Nordisk

Jacob Sten Petersen

Corporate VP, Head of Stem Cell R&D
Novo Nordisk
Fredrik Stromberg, Senior Regional Director NBS Northern Europe, Nobel Biocare Systems

Fredrik Stromberg

Senior Regional Director NBS Northern Europe
Nobel Biocare Systems
Dick Sundh, VP, Marketing & Head of Australia, Canada and Europe (ACE), Kite Pharma

Dick Sundh

VP, Head of Australia, Canada & Europe
Kite
Steve Swinson, CEO, Comphya SA

Steve Swinson

CEO
Comphya SA
Scott Tackett, Vice President - Global Access, Value & Economics at Intuitive, Intuitive Surgical

Scott Tackett

Vice President - Global Access, Value & Economics at Intuitive
Intuitive Surgical
Gregg Talbert, Senior Vice President, Head of Personalized Healthcare and Digital Partnering, Roche

Gregg Talbert

Senior Vice President, Head of Personalized Healthcare and Digital Partnering
Roche
Steffen Thirstrup, Advisory Board Director, NDA Group

Steffen Thirstrup

Advisory Board Director
NDA Group
Susan Thomas, Clinical Director, Google Health UK

Susan Thomas

Clinical Director
Google Health UK
Steve Tolle, Partner, HLM Ventures

Steve Tolle

Partner
HLM Ventures
Gadi Toren, Investment Partner, Robert Bosch Venture Capital

Gadi Toren

Investment Partner
Robert Bosch Venture Capital
Diana Torgersen, Sr Associate, Novo Ventures

Diana Torgersen

Sr Associate
Novo Ventures
Dan Vahdat, CEO, Huma

Dan Vahdat

CEO
Huma
Caoimhe Vallely-Gilroy, Head of Digital Health & Therapeutics, Healthcare Business of Merck KGaA

Caoimhe Vallely-Gilroy

Head of Digital Health & Therapeutics
Healthcare Business of Merck KGaA
Erik van den Berg, CEO, AM Pharma

Erik van den Berg

CEO
AM Pharma
Edward van Wezel, Managing Partner, Biogeneration Ventures

Edward van Wezel

Managing Partner
Biogeneration Ventures
Bonnie van Wilgenburg, Principal, Monograph Capital Partners

Bonnie van Wilgenburg

Principal
Monograph Capital Partners
Wilfred Van Zuilen, President EMEA, Zimmer Biomet

Wilfred Van Zuilen

President EMEA
Zimmer Biomet
Laurent Vandebrouck, CEO, Chronolife

Laurent Vandebrouck

CEO
Chronolife
Valerie Vanhooren, CEO, ONA Therapeutics

Valerie Vanhooren

CEO
ONA Therapeutics
Per Vegard, CEO, CMR Surgical

Per Vegard

CEO
CMR Surgical
Guillaume Vignon, SVP, Business Development, Beigene

Guillaume Vignon

SVP, Business Development
Beigene
Lea Von Bidder, CEO, Ava

Lea Von Bidder

CEO
Ava
Jill Waldner, Vice President, Evidation Health

Jill Waldner

Vice President
Evidation Health
Chris Wasden, Head, Happify Health

Chris Wasden

Head
Happify Health
Pnina Weitz, Global Head of Venture Capital Business Development & Relationship Management, Lonza

Pnina Weitz

Global Head of Venture Capital Business Development & Relationship Management
Lonza
Ethan Wergelis-Isaacson, Digital Health Strategy, Otsuka

Ethan Wergelis-Isaacson

Digital Health Strategy
Otsuka
Stephen Wildhirt, Chief Executive Officer & Co-Founder, AdjuCor

Stephen Wildhirt

Chief Executive Officer & Co-Founder
AdjuCor
Cyndi Williams, CEO, Quin

Cyndi Williams

CEO
Quin
Anna Williamson, Senior Director, Business Development, Roche

Anna Williamson

Senior Director, Business Development
Roche
Rupert Winckler, Head of EMEA BD, Olympus Corporation

Rupert Winckler

Head of EMEA BD
Olympus Corporation
Anne-Kathrin Witt, Director Digital BD&L, Novartis

Anne-Kathrin Witt

Director Digital BD&L
Novartis
Martin Witte, Senior Director Strategic Business Development, TUV SUD

Martin Witte

Senior Director Strategic Business Development
TUV SUD
Claire Woodthorpe, VP, Europe & COO, Lightpoint Medical

Claire Woodthorpe

VP, Europe & COO
Lightpoint Medical
Andreas Wüpper, Investment, EMEA, Fresenius Kabi

Andreas Wüpper

Investment, EMEA
Fresenius Kabi
Donald Xu, Managing Partner, Lynx Financial

Don Xu

Managing Director
Lynx Capital
Sarah Yusuf, Consultant Radiologists & Group Director, Sandwell and West Birmingham NHS Trust

Sarah Yusuf

Consultant Radiologists & Group Director
Sandwell and West Birmingham NHS Trust
Alexandra Zemp, Partner, McKinsey & Company

Alexandra Zemp

Partner
McKinsey & Company
Eyal Zimlichman, Chief Medical and Innovation Officer, Sheba Medical Centre

Eyal Zimlichman

Chief Medical and Innovation Officer
Sheba Medical Centre
Mai-Britt Zocca, CEO, IO Biotech

Mai-Britt Zocca

CEO
IO Biotech
DOWNLOAD BROCHURE